These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2887331)

  • 41. Gold-induced leucopenia may predict a similar adverse reaction to sulphasalazine.
    Bliddal H; Eiberg B; Helin P
    Lancet; 1987 Feb; 1(8529):390. PubMed ID: 2880198
    [No Abstract]   [Full Text] [Related]  

  • 42. Leucopenia after gold and sulphasalazine treatment.
    Schmidt KL
    Ann Rheum Dis; 1990 Jun; 49(6):422. PubMed ID: 1974412
    [No Abstract]   [Full Text] [Related]  

  • 43. Myocarditis in adult Still's disease.
    Bank I; Marboe CC; Redberg RF; Jacobs J
    Arthritis Rheum; 1985 Apr; 28(4):452-4. PubMed ID: 3986008
    [No Abstract]   [Full Text] [Related]  

  • 44. Successfully treated sulphasalazine-induced fulminant hepatic failure, thrombocytopenia and erythroid hypoplasia with intravenous immunoglobulin.
    Huang JL; Hung IJ; Chen LC; Lee WY; Hsueh C; Hsieh KH
    Clin Rheumatol; 1998; 17(4):349-52. PubMed ID: 9776124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sulphasalazine: a review of 40 years' experience.
    Watkinson G
    Drugs; 1986; 32 Suppl 1():1-11. PubMed ID: 2877847
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute leukemia after azathioprine treatment of connective tissue disease.
    Alexson E; Brandt KD
    Am J Med Sci; 1977; 273(3):335-40. PubMed ID: 266841
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Azathioprine plus prednisone compared with prednisone alone in the treatment of systemic lupus erythematosus. Report of a prospective controlled trial in 24 patients.
    Hahn BH; Kantor OS; Osterland CK
    Ann Intern Med; 1975 Nov; 83(5):597-605. PubMed ID: 1106277
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of long term evolution of adult onset and juvenile onset Still's disease, both followed up for more than 10 years.
    Cabane J; Michon A; Ziza JM; Bourgeois P; Blétry O; Godeau P; Kahn MF
    Ann Rheum Dis; 1990 May; 49(5):283-5. PubMed ID: 2344206
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
    Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1099-102. PubMed ID: 6138116
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Hypersensitivity to 5-aminosalicylic acid. Value of desensitization by oral route].
    Lachaux A; Le Gall C; Loras-Duclaux I; Aboufadel A; Hermier M
    Arch Pediatr; 1997 Feb; 4(2):144-6. PubMed ID: 9097825
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug induced intracranial hypertension associated with sulphasalazine treatment.
    Sevgi E; Yalcin G; Kansu T; Varli K
    Headache; 2008 Feb; 48(2):296-8. PubMed ID: 18070060
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adult-onset Still's disease.
    Harth M; Thompson JM; Ralph ED
    Can Med Assoc J; 1979 Jun; 120(12):1507-10. PubMed ID: 455206
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Haematological side-effects of sulphasalazine in inflammatory arthritis.
    Hopkinson ND; Saiz Garcia F; Gumpel JM
    Br J Rheumatol; 1989 Oct; 28(5):414-7. PubMed ID: 2571387
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients.
    Kurzawski M; Dziewanowski K; Gawrońska-Szklarz B; Domański L; Droździk M
    Ther Drug Monit; 2005 Aug; 27(4):435-41. PubMed ID: 16044099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.
    Smolen JS; Kalden JR; Scott DL; Rozman B; Kvien TK; Larsen A; Loew-Friedrich I; Oed C; Rosenburg R
    Lancet; 1999 Jan; 353(9149):259-66. PubMed ID: 9929017
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methotrexate and sulphasalazine as combination therapy in rheumatoid arthritis.
    Nisar M; Carlisle L; Amos RS
    Br J Rheumatol; 1994 Jul; 33(7):651-4. PubMed ID: 7912633
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sulphasalazine therapy in chronic uveitis of children with chronic arthritis.
    Huang JL; Hung IJ; Hsieh KH
    Asian Pac J Allergy Immunol; 1997 Jun; 15(2):71-5. PubMed ID: 9346269
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of sulphasalazine in the treatment of spondyloarthropathies.
    Dougados M; Maetzel A; Mijiyawa M; Amor B
    Ann Rheum Dis; 1992 Aug; 51(8):955-8. PubMed ID: 1358038
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sulphasalazine and male infertility: reversibility and possible mechanism.
    Toovey S; Hudson E; Hendry WF; Levi AJ
    Gut; 1981 Jun; 22(6):445-51. PubMed ID: 6114897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost-effectiveness and cost-utility of combination therapy in early rheumatoid arthritis: randomized comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone. COBRA Trial Group. Combinatietherapie Bij Reumatoïde Artritis.
    Verhoeven AC; Bibo JC; Boers M; Engel GL; van der Linden S
    Br J Rheumatol; 1998 Oct; 37(10):1102-9. PubMed ID: 9825750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.